\n
Every cigarette delivers over 70 known carcinogens directly to lung tissue. Every unprotected hour in the Australian sun accumulates UV-induced DNA damage in skin cells. Every asbestos fibre inhaled can remain lodged in the pleural lining for decades. Environmental diseases are non-infectious but not unpredictable — their mechanisms are well understood at the molecular level.
Use the PDF for classwork, homework or revision. It includes key ideas, activities, questions, an extend task and success-criteria proof.
Cardiovascular Disease
About 85% of lung cancers occur in smokers or ex-smokers. But approximately 15% of lung cancers occur in people who have never smoked. Meanwhile, many people who smoke heavily for decades never develop lung cancer. And most lung cancers take 20–30 years to develop from first exposure.
This pattern seems contradictory at first: smoking clearly causes lung cancer — but not in everyone who smokes, not immediately, and not exclusively.
Before reading on, answer both questions:
Q1: What does the 20–30 year latency period between first smoking and lung cancer tell you about how environmental exposures cause disease? Is it a single event or a process?
Q2: What factors other than smoking might explain why some smokers never develop lung cancer? What does this tell you about the relationship between environmental exposure and disease risk?
Connect this concept back to the broader homeostasis and disease framework you have built across the course.
Environmental diseases share three features that distinguish them from genetic diseases: they require an external exposure, they show a dose-response relationship (more exposure = higher risk), and they have a latency period (time between first exposure and disease manifestation). Understanding these three features makes every specific environmental disease in this lesson predictable from first principles.
Environmental diseases showing causes, mechanisms and examples
Dose-response relationship for threshold and non-threshold toxins
Unlike genetic diseases (which are present from conception), environmental diseases require an external agent — a carcinogen, a physical mutagen, a toxic fibre, a chemical — to initiate the disease process. Remove the exposure and the disease does not occur. This is why tobacco-related lung cancer rates fell dramatically in countries that implemented smoking bans and anti-smoking campaigns — the exposure was reduced at population level.
The probability of developing an environmental disease increases with the cumulative dose of the exposure — not just whether exposure occurred but how much and for how long. A person who smoked 20 cigarettes per day for 40 years has a much higher lung cancer risk than one who smoked 5 per day for 5 years. This is quantified by the 'pack-year' measure (packs per day × years smoked). The dose-response relationship provides the epidemiological evidence that links exposures to diseases (this will be revisited in L12–L14 on epidemiology).
Each exposure to a carcinogen or mutagen creates a small probability of a DNA mutation in an exposed cell. Single mutations rarely cause cancer — most are repaired by DNA repair enzymes, cause cell death (apoptosis), or produce non-harmful changes. Cancer requires the accumulation of multiple mutations in key genes (oncogenes and tumour suppressors) within the same cell line.
More exposure = more mutations per cell per year = higher probability that the required combination of mutations accumulates in a single cell = higher risk. The latency period represents the time needed for sufficient mutations to accumulate. This is why lung cancer takes 20–30 years to develop from first smoking: multiple independent mutations in the same cell must accumulate over that time for a lung cancer to arise.
Environmental diseases rarely manifest immediately after first exposure. Most have a latency period — the time between first exposure and clinical disease — ranging from years (some chemical exposures) to decades (asbestos: 20–50 years; tobacco: 20–30 years). This latency makes it difficult for individuals to perceive the harm from ongoing exposure and creates public health communication challenges. It also means that even after cessation of exposure, the risk remains elevated for years — though it does decline over time.
Tobacco smoke is one of the most studied environmental carcinogens. Its effects on the body span three distinct disease pathways — mutagenic damage leading to cancer, inflammatory/toxic damage leading to COPD, and vascular damage leading to cardiovascular disease — each operating through a different molecular mechanism.
Carcinogens in tobacco smoke (particularly polycyclic aromatic hydrocarbons like benzopyrene) are absorbed across the bronchial epithelium and metabolically activated in bronchial cells to reactive electrophilic forms. These electrophiles covalently bond to DNA bases, forming DNA adducts — distortions that cause errors during DNA replication. If these adducts form in critical proto-oncogenes (e.g. KRAS) or tumour suppressor genes (e.g. TP53, which encodes p53), the resulting mutations may initiate the cancer development process.
With continued smoking, additional mutations accumulate over years to decades. When enough mutations accumulate in a single bronchial cell — disabling cell cycle checkpoints (p53), activating growth signals (KRAS), and disabling apoptosis — that cell line begins to proliferate uncontrollably → lung cancer. Approximately 85% of lung cancers are attributable to smoking.
Tobacco smoke irritants (not only carcinogens) trigger a chronic inflammatory response in the airways. Macrophages and neutrophils recruited to the airways release proteases (particularly elastase) that break down the elastin in the alveolar walls. Progressive destruction of alveolar walls reduces the surface area for gas exchange and eliminates the elastic recoil that drives exhalation → emphysema. Simultaneously, chronic irritation stimulates mucus-secreting cells to proliferate and produce excess mucus, obstructing small airways → chronic bronchitis. Together these produce COPD — progressive, largely irreversible airflow obstruction.
Tobacco smoke chemicals damage the endothelial lining of blood vessels, triggering an inflammatory response. Nicotine causes vasoconstriction and increases heart rate and blood pressure. Carbon monoxide in smoke binds haemoglobin more tightly than O₂ (forming carboxyhaemoglobin), reducing oxygen-carrying capacity. Chronic endothelial damage promotes atherosclerosis — lipid-laden plaques accumulate in artery walls, narrowing vessels and increasing the risk of thrombosis, heart attack, and stroke.
UV radiation is a physical mutagen — it does not form DNA adducts like chemical carcinogens, but instead directly alters DNA structure by causing covalent bonds to form between adjacent pyrimidine bases. The result is the same: DNA damage that, if unrepaired, produces mutations during replication.
UV-B photons are absorbed by adjacent thymine bases on the same DNA strand. The absorbed energy causes a photochemical reaction — a cyclobutane ring forms between the two thymines, creating a thymine dimer (also called a cyclobutane pyrimidine dimer, CPD). This dimer distorts the DNA double helix at that point, preventing normal base pairing and blocking DNA polymerase during replication.
The body has nucleotide excision repair (NER) enzymes that normally recognise and excise thymine dimers, replacing them with correctly synthesised nucleotides. This repair is highly efficient in most cells. However, when UV exposure is intense or frequent, the rate of dimer formation exceeds the repair capacity — unrepaired dimers persist through DNA replication and cause mutations. Typical UV-induced mutations produce characteristic CC→TT transitions (a 'signature mutation' specific to UV damage) in skin cell DNA.
In melanocytes, UV-induced mutations accumulate over time. Mutations in the BRAF oncogene (present in ~60% of melanomas, particularly V600E mutation) activate the MAPK/ERK signalling pathway, driving uncontrolled melanocyte proliferation. Additional mutations disabling CDKN2A (encoding p16 — a tumour suppressor) remove the cell cycle brake. The combination of oncogene activation and tumour suppressor inactivation produces invasive melanoma.
Non-melanoma skin cancers (basal cell carcinoma, squamous cell carcinoma) arise from keratinocytes through the same UV-damage mechanism but in different cell types, with different mutational targets and lower metastatic potential than melanoma.
Asbestos provides a mechanistically distinct example of environmental disease — one caused not by a chemical mutagen or radiation, but by the physical properties of a durable inorganic fibre that the body cannot break down. The mechanism involves chronic inflammation, free radical generation, and mechanical DNA damage rather than direct chemical interaction with DNA.
When asbestos fibres are inhaled, the longer fibres (>5 μm) cannot be completely engulfed by alveolar macrophages — the macrophages attempt but fail to phagocytose them, resulting in 'frustrated phagocytosis.' The macrophages release reactive oxygen species (ROS) and inflammatory cytokines in a prolonged, unsuccessful attempt to degrade the fibres.
These ROS directly damage DNA in adjacent mesothelial cells lining the pleura. The chronic inflammatory environment also promotes cell proliferation (healing response) — increasing the rate at which mutations are replicated and propagated. Over 20–50 years, cumulative DNA damage in mesothelial cells — particularly mutations in tumour suppressor genes (BAP1, NF2, CDKN2A) — leads to malignant mesothelioma.
The extreme latency (20–50 years) reflects both the slow rate of DNA damage accumulation and the fact that mesothelioma requires multiple mutations in a cell type with a very slow baseline turnover rate (mesothelial cells divide slowly, so mutations take longer to propagate into a detectable tumour mass).
Australia was one of the world's largest per-capita users of asbestos — used extensively in building materials (fibro sheeting, roof tiles, insulation, pipes) from the 1940s to the 1980s. Asbestos was banned in Australia in 2003. However, because of the 20–50 year latency, Australia continues to see rising mesothelioma rates from exposures that occurred decades ago. Australia has one of the world's highest mesothelioma rates — approximately 700 deaths per year.
Epigenetics describes heritable changes in gene expression that do not involve changes to the DNA sequence itself. Environmental exposures — including tobacco smoke, UV radiation, diet, stress, and pollution — can alter epigenetic marks on DNA and histones, switching genes on or off without mutating them. This provides a molecular mechanism for how the environment modifies the expression of genetic predisposition.
DNA methylation: The addition of a methyl group (–CH₃) to cytosine bases in CpG dinucleotides. When the promoter region of a gene is heavily methylated, transcription factors cannot bind → gene is silenced. Environmental carcinogens (tobacco smoke, air pollution) can cause abnormal methylation of tumour suppressor gene promoters — effectively silencing genes like p16 (CDKN2A) without mutating them. The result is the same as a loss-of-function mutation: the tumour suppressor is inactive, removing a brake on cell division.
Histone modification: Histones are the proteins around which DNA is wound. Adding or removing chemical groups (acetyl, methyl, phosphate) to histone tails changes how tightly DNA is wound → affects accessibility to transcription machinery → alters gene expression. Environmental exposures can alter histone modification patterns, changing the expression of many genes simultaneously.
Epigenetic changes explain several phenomena that genetic mutation alone cannot:
In December 2012, Australia became the first country in the world to mandate plain packaging for tobacco products — removing brand logos and colours from cigarette packets and replacing them with large graphic health warnings. The policy was based on evidence that branded packaging acts as advertising that normalises and promotes smoking.
Studies tracking the policy's effects found a measurable reduction in smoking prevalence in the years following implementation, particularly among young people. By 2022, Australian adult smoking rates had fallen to approximately 11% — one of the lowest rates in the world, down from roughly 25% in the early 1990s.
This demonstrates the dose-response principle in reverse: reduce population-level exposure to a carcinogen (tobacco) and, after a latency period, population-level lung cancer rates fall. Australian lung cancer mortality rates have been declining since the 1990s — largely tracking the decline in smoking rates that began decades earlier. The 20–30 year latency between smoking and lung cancer means the full benefit of the current low smoking rates will not be seen in mortality statistics until the 2030s–2040s.
"Smoking always causes lung cancer." — Smoking greatly increases the risk of lung cancer but does not guarantee it. The relationship is probabilistic: a lifetime heavy smoker has approximately 10–25× the lung cancer risk of a non-smoker, but the majority of heavy smokers do not develop lung cancer. DNA repair efficiency, genetic susceptibility to carcinogens, and other factors modify individual risk. Risk ≠ certainty.
"Epigenetic changes are the same as genetic mutations." — Epigenetic changes alter gene expression without changing the DNA nucleotide sequence. A methylated promoter silences a gene, but the gene's sequence is intact. A genetic mutation changes the actual DNA nucleotide sequence. The distinction matters: epigenetic changes can sometimes be reversed (by environmental modification or drugs); most mutations cannot.
"Mesothelioma is caused by the chemical content of asbestos." — Mesothelioma is caused by the physical properties of asbestos fibres — their shape, durability, and biopersistence. Asbestos is chemically inert. It is the mechanical inability of macrophages to degrade the fibres that leads to frustrated phagocytosis, chronic ROS release, and DNA damage. The disease mechanism is physical, not chemical.
"UV causes skin cancer by 'burning' skin cells." — Sunburn is a physiological response (inflammation, increased blood flow) to UV damage, but the cancer risk comes from UV-induced thymine dimer formation in DNA — not from the burn itself. Tanning without burning still accumulates DNA damage. The absence of a visible burn does not mean the absence of mutagenic DNA damage.
"Environmental diseases only affect people in high-risk occupations." — While occupational exposure (asbestos workers, outdoor labourers) creates higher dose exposures, environmental diseases can affect anyone. Every Australian accumulates UV-induced DNA damage through everyday outdoor activities. Second-hand tobacco smoke is an environmental exposure for non-smokers. Air pollution affects entire urban populations. The dose is different, but the exposure and mechanism are the same.
Image Slot 1: Diagram showing tobacco carcinogen → DNA adduct mechanism: benzopyrene enters bronchial cell → metabolically activated to diol epoxide → covalently bonds to guanine in DNA → adduct distorts helix → error during DNA replication → G→T transversion mutation → if in TP53 or KRAS → cancer initiation. Compare with UV → thymine dimer pathway in the same diagram.
Image Slot 2: Epigenetics normal gene with unmethylated promoter (transcription factor can bind, gene expressed) vs methylated promoter (methyl groups on CpG sites, transcription factor cannot bind, gene silenced). Environmental exposure (tobacco smoke arrow) causes hypermethylation of tumour suppressor promoter → tumour suppressor silenced → cell cycle unregulated.
Try this: Drag the carcinogen events onto the timeline to see how exposure, latency, and disease manifestation unfold over decades.
This timeline illustrates why environmental diseases often appear long after the original exposure, making causation difficult to establish.
Carcinogens cause DNA mutations that accumulate over years or decades before cancer becomes detectable. This long latency period means that by the time disease appears, the original exposure may have ceased. This is why prevention and early screening are critical.
Try this: Classify each risk factor as modifiable or non-modifiable, and as chemical, physical, or biological.
This classifier helps you distinguish between risks that can be changed through behaviour and those that cannot.
Environmental risk factors include chemical (asbestos, benzene), physical (UV radiation, ionising radiation), and biological (aflatoxins, HPV) agents. Modifiable risks can be reduced through public health policy and personal behaviour; non-modifiable risks require screening and monitoring.
1 A 65-year-old man who worked as a plumber from 1968 to 1995, frequently cutting fibro (asbestos-containing) sheeting, is diagnosed with a cancer of the lining of his lungs.
2 A 42-year-old woman in Queensland who spent her teens working as a beach lifeguard (8 hours/day outdoors, summer and winter) is diagnosed with melanoma on her back.
3 A 58-year-old man who smoked 25 cigarettes per day from age 16 to age 50 (34 years) now has severe breathlessness and is diagnosed with emphysema. He does not have lung cancer.
4 Research shows that tobacco smoke exposure causes hypermethylation of the CDKN2A (p16) gene promoter in bronchial epithelial cells, even in the absence of direct mutations in CDKN2A.
5 An epidemiological study finds that the lung cancer risk in asbestos workers who smoke is approximately 50 times higher than the baseline population risk, while non-smoking asbestos workers have only about 5 times the baseline risk, and non-asbestos smokers have about 10 times the baseline risk. What does this suggest about the interaction between these two environmental exposures?
1 A 50-year-old non-smoker develops lung cancer. Use your knowledge of environmental disease, epigenetics, and multifactorial disease to explain three possible pathways by which this person could have developed lung cancer without smoking. For each pathway, identify the exposure and molecular mechanism.
2 Explain how epigenetic changes caused by environmental exposures represent a molecular mechanism for the concept of multifactorial disease introduced in L06. Use tobacco smoke and CDKN2A methylation as your example. Your answer should connect: (a) genetic predisposition (some people have less effective DNA repair enzymes — a genetic variant); (b) environmental exposure (tobacco smoke); (c) epigenetic change (CDKN2A methylation); (d) cancer outcome.
1. Which statement correctly explains why asbestos causes mesothelioma through a different mechanism than tobacco smoke causes lung cancer?
2. UV-B radiation causes skin cancer primarily through which molecular mechanism?
3. Research shows that tobacco smoke can silence the CDKN2A tumour suppressor gene by causing hypermethylation of its promoter, even without directly mutating the gene. Which statement best explains the significance of this finding?
4. A patient who has never smoked asks whether they can still develop lung cancer. Which response is most scientifically accurate?
5. Australia's smoking rate has fallen from ~72% of adult males in 1945 to ~11% today. Lung cancer mortality rates have been declining since the 1990s. A student argues: "This proves that smoking reduction is the direct cause of the lung cancer mortality decline." Evaluate this claim, including reference to the dose-response relationship and latency period.
6. Explain how UV radiation causes melanoma. In your answer, describe the specific molecular mechanism (including the name of the DNA lesion formed), explain what happens if this lesion is not repaired before DNA replication, and identify the genes most commonly mutated in melanoma. 4 MARKS
7. Tobacco smoking causes both lung cancer and COPD (emphysema), yet these two diseases arise through different mechanisms. Compare the molecular mechanism by which smoking causes each disease, explaining why one involves DNA mutation and cell cycle disruption while the other primarily involves tissue destruction through chronic inflammation. 5 MARKS
8. Explain what epigenetics is and evaluate its significance for understanding environmental disease. In your answer: define epigenetics and distinguish it from genetic mutation; describe one specific epigenetic mechanism (DNA methylation or histone modification); explain how an environmental exposure can produce an epigenetic change that contributes to cancer; and explain why this is significant for our understanding of gene-environment interaction. 6 MARKS
Return to your Think First responses at the start of the lesson.
1. Plumber/asbestos: (a) Asbestos fibres (amphibole asbestos from fibro sheeting, inhaled during cutting). (b) Inhaled asbestos fibres lodge in the pleural lining — macrophages attempt phagocytosis but cannot degrade the fibres (frustrated phagocytosis) → release ROS and inflammatory cytokines → chronic oxidative DNA damage in mesothelial cells lining the pleura → accumulated mutations in BAP1, NF2, CDKN2A tumour suppressors. (c) Mesothelioma — malignant cancer of the pleural lining. (d) Dose-response: yes — more fibre exposure (more years cutting fibro, higher fibre concentration) = greater cumulative DNA damage = higher mesothelioma risk. The 20–50 year gap reflects the extremely slow turnover of mesothelial cells (mutations propagate slowly) and the multiple mutations required for cancer to manifest.
2. Queensland lifeguard/melanoma: (a) UV-B radiation — 8 hours/day outdoor exposure at high Queensland UV index, cumulated over years of lifeguard work. (b) UV-B photons cause thymine dimer (CPD) formation between adjacent thymine bases in melanocyte DNA. If unrepaired before replication, CC→TT transitions occur. In melanocytes, BRAF V600E mutation (MAPK pathway activation) and CDKN2A inactivation are typical. (c) Melanoma — malignant cancer of melanocytes. (d) Dose-response: yes — cumulative lifetime UV dose (not single sunburn events alone) determines risk. This person's extremely high daily UV exposure over many years accumulates a large total dose, dramatically increasing the probability that sufficient mutations accumulate in a melanocyte.
3. Emphysema from smoking: (a) Tobacco smoke (25 cigarettes/day for 34 years = 25/20 × 34 = 42.5 pack-years — very high). (b) Emphysema mechanism (distinct from lung cancer): tobacco smoke irritants trigger chronic recruitment of macrophages and neutrophils to airways. These immune cells release elastase (a protease) that degrades elastin in alveolar walls. Progressive loss of alveolar walls reduces gas exchange surface area and eliminates elastic recoil. Simultaneously, goblet cell hyperplasia produces excess mucus → chronic bronchitis. Together = COPD. (c) Emphysema (type of COPD). Why not lung cancer: the two diseases arise through different mechanisms (tissue destruction via inflammation vs DNA mutation via carcinogens). Having emphysema does not preclude lung cancer — this person may yet develop it — but the probability varies between individuals based on genetic susceptibility to carcinogens, DNA repair efficiency, and other factors. (d) 42.5 pack-years — extremely high dose, consistent with very high COPD and lung cancer risk.
4. CDKN2A methylation: (a) Tobacco smoke (the environmental exposure that causes the epigenetic change). (b) Tobacco smoke components (or their metabolic products) promote hypermethylation of CpG sites in the CDKN2A promoter region. With the promoter methylated, transcription factors cannot bind → CDKN2A gene is silenced → p16 protein is not produced → p16 normally inhibits CDK4/6 (cyclin-dependent kinases) which would otherwise phosphorylate Rb → without p16, CDK4/6 remain active → Rb is phosphorylated → E2F transcription factors released → cell cycle progression into S phase is uninhibited → cell can divide without normal checkpoint regulation. (c) Loss of p16 removes a critical G1/S cell cycle checkpoint → cells with damaged DNA can continue dividing → increased cancer risk. (d) This is an epigenetic change — the DNA sequence of CDKN2A has not changed (cytosines are still cytosines); only the methylation pattern of those cytosines has changed. In contrast, a genetic mutation would involve a change in the nucleotide sequence (e.g. a point mutation creating a stop codon in CDKN2A). Both have the same functional outcome (loss of p16 function) but through different mechanisms.
5. Synergistic interaction: If the effects were simply additive: asbestos risk (5×) + smoking risk (10×) = 15× baseline. Observed: 50×. This is a synergistic interaction — the two exposures together produce a risk far greater than the sum of their individual risks. Biological explanation: asbestos fibres cause chronic inflammation and ROS-mediated DNA damage; tobacco carcinogens cause direct DNA adducts and mutations. Both act on the same cell type (bronchial epithelium) and converge on the same oncogenic pathway (p53 and Rb inactivation). Additionally, asbestos fibres impair mucociliary clearance, increasing the residence time of tobacco carcinogens in the airways — increasing dose from tobacco smoke. Finally, asbestos-driven chronic inflammation creates a pro-proliferative microenvironment that accelerates the propagation of tobacco-induced mutations.
1. Non-smoker lung cancer pathways: Pathway 1 — Radon gas exposure: radon is a naturally occurring radioactive gas produced by uranium decay in soil and rock. It is the leading cause of lung cancer in non-smokers in some regions. Radon decay products emit alpha radiation that directly ionises DNA in bronchial cells → strand breaks and mutations → lung cancer. Pathway 2 — Second-hand tobacco smoke exposure: passive inhalation of exhaled tobacco smoke and smoke from burning cigarettes contains the same carcinogens as primary smoke. Prolonged second-hand smoke exposure (e.g. living with a heavy smoker for decades) causes DNA adduct formation in bronchial cells of non-smokers by the same mechanism as active smoking. Pathway 3 — Air pollution (particulate matter and chemical carcinogens): outdoor air pollution (from vehicle exhausts, industrial emissions) contains fine particulate matter (PM2.5) and chemical carcinogens (benzopyrene, formaldehyde). These are inhaled, absorbed across the bronchial epithelium, and form DNA adducts in lung cells. The WHO classified outdoor air pollution as a Group 1 carcinogen in 2013.
2. Epigenetics and multifactorial disease: (a) Genetic predisposition: individuals with genetic variants that reduce the efficiency of nucleotide excision repair (NER) enzymes (e.g. polymorphisms in XPC, ERCC1/2 genes) are less able to repair tobacco-induced DNA adducts and epigenetic changes → greater accumulation of mutations per pack-year of smoking. (b) Environmental exposure: tobacco smoke carcinogens cause both direct DNA adducts (chemical mutations) and epigenetic reprogramming of bronchial cells — including hypermethylation of tumour suppressor gene promoters such as CDKN2A. (c) Epigenetic change: CDKN2A hypermethylation silences p16 expression in bronchial cells → p16 protein absent → CDK4/6 uninhibited → Rb hyperphosphorylated → E2F released → uncontrolled G1→S transition → cells that should arrest for DNA repair continue dividing. (d) Cancer outcome: the combination of (a) reduced DNA repair capacity (genetic), (b) direct DNA mutations from carcinogens (environmental), and (c) epigenetic silencing of a tumour suppressor (epigenetic) creates a triple hit on the cell's cancer protection systems. Each factor alone might not produce cancer; together they dramatically exceed the threshold of mutations required for malignant transformation. Connection to multifactorial disease (L06): this precisely illustrates why multifactorial disease cannot be attributed to a single cause — genetic predisposition (repair gene variants) sets the baseline susceptibility; environmental exposure (smoke) provides the mutagen and epigenetic disruptor; the two interact to produce an outcome (lung cancer) that neither alone would reliably produce.
1. B — Asbestos: physical biopersistence → frustrated phagocytosis → ROS → indirect DNA damage. Tobacco: chemical carcinogens directly form DNA adducts. Option A reverses the mechanisms. Option C incorrectly states both use the same mechanism. Option D is fabricated.
2. C — UV-B → cyclobutane pyrimidine dimers (thymine dimers) between adjacent thymines → if unrepaired → CC→TT mutations → BRAF activation or CDKN2A inactivation → melanoma. Option A is incorrect about UV destroying cancer cells. Option B incorrectly describes UV as forming chemical adducts (that is tobacco). Option D incorrectly attributes UV to an epigenetic mechanism.
3. D — CDKN2A methylation by tobacco smoke silences p16 (a tumour suppressor) without mutating the gene — producing the same functional outcome as a loss-of-function mutation through an epigenetic mechanism. This demonstrates that environmental exposures can cause both genetic and epigenetic changes that converge on the same oncogenic consequence. Option A is wrong — methylation of tumour suppressor promoters increases cancer risk. Option B is wrong — this is harmful, not beneficial. Option C overstates the case — tobacco also causes direct mutations.
4. A — Non-smokers account for ~15% of lung cancers. Causes include radon, second-hand smoke, air pollution, occupational carcinogens, random somatic mutations, and genetic susceptibility alleles (e.g. variants in EGFR, ALK). Option B is wrong — non-smokers can develop lung cancer. Option C is wrong — BRCA1 is not a primary lung cancer gene. Option D understates the causes.
5. C — The correlation between declining smoking rates and declining lung cancer mortality is real and almost certainly causal — consistent with dose-response relationships (less exposure = less disease). However, the claim that it is 'direct' overstates epidemiological inference (correlation ≠ proven causation without controlling confounders, though the evidence is very strong). The 20–30 year latency is critical: 1990s mortality declines reflect 1960s–1970s smoking behaviour. Treatment improvements (surgery, chemotherapy, targeted therapy) also independently reduce mortality. Options A and D are too extreme in opposite directions.
Q6 (4 marks): UV-B radiation from sunlight is absorbed by adjacent thymine bases on the same DNA strand in melanocytes (the pigment-producing cells of the skin). The absorbed energy causes a photochemical reaction forming a covalent cyclobutane ring between the two thymine bases — this is called a thymine dimer (or cyclobutane pyrimidine dimer, CPD) [1 mark]. The thymine dimer distorts the DNA double helix at that site, preventing normal Watson-Crick base pairing and blocking DNA polymerase during replication [1 mark]. If the dimer is not repaired by nucleotide excision repair (NER) before the cell divides, DNA polymerase either stalls or inserts incorrect bases opposite the dimer — typically producing CC→TT or C→T transition mutations. These are UV-signature mutations specific to this mechanism [1 mark]. In melanocytes, if these mutations occur in the BRAF proto-oncogene (most commonly the V600E point mutation, which constitutively activates the MAPK/ERK growth signalling pathway) or in the CDKN2A tumour suppressor gene (encoding p16, which normally restrains cell cycle progression), the cell can begin to divide uncontrollably → melanoma [1 mark — 4 marks total].
Q7 (5 marks): Lung cancer mechanism: tobacco smoke contains over 70 carcinogens, particularly polycyclic aromatic hydrocarbons (e.g. benzopyrene). These are absorbed across the bronchial epithelium and metabolically activated to reactive electrophilic forms that covalently bond to DNA bases in bronchial epithelial cells — forming DNA adducts. Adducts cause errors during DNA replication → mutations in proto-oncogenes (KRAS — activating growth signals) and tumour suppressor genes (TP53 — disabling apoptosis and cell cycle arrest). With continued smoking, multiple mutations accumulate in the same cell line over 20–30 years → sufficient mutations to initiate uncontrolled cell division → lung cancer [2 marks]. COPD/emphysema mechanism: tobacco smoke irritants (not primarily carcinogens) trigger chronic inflammation in the airways. Alveolar macrophages and neutrophils are continuously recruited → these immune cells release proteolytic enzymes, particularly elastase. Elastase degrades elastin — the protein that gives alveolar walls their elastic recoil. Progressive destruction of alveolar walls reduces gas exchange surface area and eliminates the elastic recoil that drives passive exhalation → air trapping → emphysema. Simultaneously, chronic irritation causes goblet cell hyperplasia, producing excess mucus that obstructs small airways → chronic bronchitis [2 marks]. Key difference: lung cancer involves mutagenic damage to DNA, disrupting cell cycle regulation and causing uncontrolled cell division — a process requiring decades of accumulated mutations. COPD involves inflammatory tissue destruction — proteolytic degradation of lung architecture without necessarily involving cancer-causing mutations — and can begin within years of smoking onset without DNA mutation in proto-oncogenes [1 mark — 5 marks total].
Q8 (6 marks): Definition and distinction: epigenetics refers to heritable changes in gene expression that do not involve alterations to the DNA nucleotide sequence. In contrast, a genetic mutation involves an actual change in the DNA sequence — a different nucleotide is present. An epigenetic change leaves the sequence intact but modifies how that sequence is expressed — whether the gene is accessible for transcription. Epigenetic changes can sometimes be reversed; most genetic mutations cannot [1 mark]. DNA methylation mechanism: the most studied epigenetic mechanism is DNA methylation — the addition of a methyl group (–CH₃) to cytosine bases at CpG dinucleotide sites, catalysed by DNA methyltransferase enzymes. When the promoter region of a gene contains multiple methylated CpG sites, the methylation attracts methyl-binding proteins that compact the chromatin and prevent transcription factors from binding to the promoter → the gene is transcriptionally silenced, even though its sequence is intact [2 marks]. Environmental exposure example: tobacco smoke components can cause hypermethylation of the CDKN2A promoter (the gene encoding p16, a key tumour suppressor) in bronchial epithelial cells. When CDKN2A is silenced by methylation, p16 protein is not produced. p16 normally inhibits cyclin-dependent kinases (CDK4/6) that drive the G1→S transition in the cell cycle. Without p16, CDK4/6 remain active → Rb is hyperphosphorylated → E2F transcription factors are released → cells proceed through S phase without the normal G1 checkpoint — the same functional consequence as a loss-of-function mutation in CDKN2A, but achieved without changing the DNA sequence [2 marks]. Significance for gene-environment interaction: this finding is significant because it demonstrates that environmental exposures can produce the same functional outcomes as genetic mutations through a different mechanism — one that does not require permanent DNA sequence change. It also explains why individuals with the same genetic sequence can have different cancer susceptibility depending on their environmental exposure history: epigenetic patterns differ based on what environmental exposures have occurred. This is a molecular explanation for the gene-environment interaction that underlies multifactorial disease — genetic predisposition (e.g. less efficient NER enzymes) combined with environmental epigenetic reprogramming (e.g. tobacco smoke methylating tumour suppressors) produces cancer risk that neither factor alone reliably predicts [1 mark — 6 marks total].
Defend your ship by blasting the correct answers for Environmental Diseases — Smoking, UV Exposure, Asbestos and Lifestyle Factors. Scores count toward the Asteroid Blaster leaderboard.
Play Asteroid Blaster →Tick when you have finished all activities and checked your answers.